Survival benefit of eculizumab in patients with paroxysmal nocturnal hemoglobinuria

被引：0

作者：

Patel, Ami ^{[1
]}

Metzger, Jesse ^{[2
]}

Terriou, Louis ^{[3
]}

Patriquin, Christopher ^{[4
]}

Griffin, Morag ^{[5
]}

Lee, Jong Wook ^{[6
]}

Gustovic, Phillippe ^{[7
]}

Jiang, Wei ^{[7
]}

Szer, Jeff ^{[8
,9
]}

机构：

[1] Alex Pharmaceut, New Haven, CT USA

[2] Parexel Int, Newton, MA USA

[3] CHU Lille, Serv Med Interne & Immunol Clin, Lille, France

[4] Univ Toronto, Div Med Oncol & Hematol, Univ Hlth Network, Toronto, ON M5S 1A1, Canada

[5] Leeds Teaching Hosp NHS Trust, Dept Hematol, Leeds, W Yorkshire, England

[6] Catholic Univ Korea, Dept Hematol, Seoul St Marys Hosp, Seoul, South Korea

[7] Alexion, AstraZeneca Rare Dis, Boston, MA USA

[8] Peter MacCallum Canc Ctr, Dept Clin Hematol, Melbourne, Vic, Australia

[9] Royal Melbourne Hosp, Melbourne, Vic, Australia

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

586

引用

页码：264 / 265

页数：2

共 50 条

[1] Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
Marti-Carvajal, Arturo J.
Anand, Vidhu
Felipe Cardona, Andres
Sola, Ivan
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
[2] Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
Kelly, Richard J.
Hoechsmann, Britta
Szer, Jeff
Kulasekararaj, Austin
Path, F. R. C.
de Guibert, Sophie
Roeth, Alexander
Weitz, Ilene C.
Armstrong, Elina
Risitano, Antonio M.
Patriquin, Christopher J.
Terriou, Louis
Muus, Petra
Hill, Anita
Turner, Michelle P.
Schrezenmeier, Hubert
de latour, Regis Peffault
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (11): : 1032 - 1039
[3] Paroxysmal nocturnal hemoglobinuria and eculizumab
Luzzatto, Lucio
Risitano, Antonio Maria
Notaro, Rosario
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (04): : 523 - 526
[4] Eculizumab in paroxysmal nocturnal hemoglobinuria
Socie, Gerard
Varoqueaux, Nathalie
de Latour, Regis Peffault
[J]. M S-MEDECINE SCIENCES, 2009, 25 (12): : 1126 - 1129
[5] Clinical Benefit of Eculizumab in Patients with No Transfusion History in the International Paroxysmal Nocturnal Hemoglobinuria Registry
Almeida, Antonio Medina
Bedrosian, Camille L.
Cole, Alexander
Muus, Petra
Schrezenmeier, Hubert
Szer, Jeff
Urbano-Ispizua, Alvaro
Rosse, Wendell F.
[J]. BLOOD, 2015, 126 (23)
[6] Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Hill, Anita
[J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1467 - 1476
[7] Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1270): : 79 - 80
[8] The clinical benefit of eculizumab is demonstrable in all subpopulations of patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis
Muus, P.
Duehrsen, U.
Elebute, M.
Browne, P.
Urbano-Ispizua, A.
Coutre, S.
Van Den Neste, E.
De Paz, R.
Konkle, B.
Moskovits, T.
Nakamura, R.
Zanella, A.
Hillmen, P.
Rother, R. P.
Soci, G.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 137 - 138
[9] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
Rodriguez-Garcia, Juan
Fernandez-Santos, Rafael
Antonio Garcia-Erce, Jose
[J]. MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
[10] Antiphospholipid antibodies in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
Helley, D.
Darnige, L.
de Latour, R. P.
Zemori, L.
Socie, G.
Fischer, A-M
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 624 - 624

← 1 2 3 4 5 →